Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Mude Shi"'
Autor:
Wentao Pan, Qiuyun Luo, Eric Liang, Mude Shi, Jian Sun, Huimin Shen, Zhenhai Lu, Lin Zhang, Xianglei Yan, Luping Yuan, Suna Zhou, Hanjie Yi, Yifan Zhai, Miao-zhen Qiu, Dajun Yang
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Immune checkpoint inhibitors are approved for the treatment of various tumors, but the response rate is not satisfactory in certain malignancies. Inhibitor of apoptosis proteins (IAP) ubiquitin-E3 ligase activity is involved in th
Externí odkaz:
https://doaj.org/article/351b402f688449ceb4c6ca9f401e8dfc
AM-DMF-SCP: Integrated Single-Cell Proteomics Analysis on an Active Matrix Digital Microfluidic Chip
Autor:
Zhicheng Yang, Kai Jin, Yimin Chen, Qian Liu, Hongxu Chen, Siyi Hu, Yuqiu Wang, Zilu Pan, Fang Feng, Mude Shi, Hua Xie, Hanbin Ma, Hu Zhou
Publikováno v:
JACS Au, Vol 4, Iss 5, Pp 1811-1823 (2024)
Externí odkaz:
https://doaj.org/article/9bbeb21866e749eeb0176b1b37d88d5c
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundAccumulating evidence has revealed that CD8+ T cell exhaustion (Tex) results in worse immunotherapy outcomes. However, the molecular functions and mechanisms of action of Tex in chemoresistance needed to be elucidated.MethodsThe populations
Externí odkaz:
https://doaj.org/article/88321b892a3049b8a5c1602cbc6da5d6
Autor:
Chunlian Zhou, Weiwei Xiao, Ting Jiang, Zhiwei Guo, Min Li, Hui Chang, Yingsong Wu, Minshan Chen, Mude Shi, Weiwen Xu, Yuanhong Gao
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 125, Iss , Pp 109954- (2020)
Radiotherapy (RT) is a key component of neoadjuvant chemoradiotherapy to treat locally advanced rectal cancer (LARC). However, the therapeutic effect is limited due to radioresistance. Investigating the biomarkers of radioresistance might assist in t
Externí odkaz:
https://doaj.org/article/a86069b40d714c0da259f6c1a344a97e
Autor:
James Bowman, Mary A. Rodgers, Mude Shi, Rina Amatya, Bruce Hostager, Kazuhiro Iwai, Shou-Jiang Gao, Jae U. Jung
Publikováno v:
mBio, Vol 6, Iss 6 (2015)
ABSTRACT Linear ubiquitination is an atypical posttranslational modification catalyzed by the linear-ubiquitin-chain assembly complex (LUBAC), containing HOIP, HOIL-1L, and Sharpin. LUBAC facilitates NF-κB activation and inflammation upon receptor s
Externí odkaz:
https://doaj.org/article/7b17e42dd58d43dbad7b1292f30f24fd
Autor:
Cai, D. Q., Diankui Cai, Yiping Zou, Xumeng Chen, Zhixiang Jian, Mude Shi, Ye Lin, Jueming Chen
Publikováno v:
Frontiers in Immunology; 3/6/2023, Vol. 14, p1-16, 16p
Autor:
Zhongguo Zhou, Yaojun Zhang, Juncheng Wang, Minshan Chen, Ziming He, Li Xu, Jinbin Chen, Mude Shi
Publikováno v:
European Journal of Gastroenterology & Hepatology
Background: Hepatitis B surface antigen (HBsAg) is a detectable index after hepatitis B virus (HBV) infection, which is a risk factor of hepatocellular carcinoma (HCC). However, few studies have focused on the expression of HBsAg in HCC patients’ l
Autor:
Yuanhong Gao, Minshan Chen, Mude Shi, Ting Jiang, Min Li, Weiwei Xiao, Weiwen Xu, Zhi-Wei Guo, Hui Chang, Chun-Lian Zhou, Ying-Song Wu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 125, Iss, Pp 109954-(2020)
Radiotherapy (RT) is a key component of neoadjuvant chemoradiotherapy to treat locally advanced rectal cancer (LARC). However, the therapeutic effect is limited due to radioresistance. Investigating the biomarkers of radioresistance might assist in t
Autor:
Zhenhai Lu, Jian Sun, Hanjie Yi, Guangfeng Wang, Mengxian Pan, Huimin Shen, Qiuyun Luo, Douglas D. Fang, Xianglei Yan, Miao Zhen Qiu, Dajun Yang, Lin Zhang, Suna Zhou, Mude Shi, Luping Yuan, Wentao Pan, Yifan Zhai, Yuxin Zhang
Publikováno v:
SSRN Electronic Journal.
Background: Immune checkpoint inhibitor has got indication in various tumors, but the response rate was not satisfying. Identification of predictive biomarkers and novel combinations may enhance the response rate. Inhibitor of apoptosis proteins (IAP
Autor:
Yuhao Tang, Xiao-Hui Wang, Yaojun Zhang, Minshan Chen, Li Xu, Juncheng Wang, Mude Shi, Yi-Zhen Fu, Zhongguo Zhou
Publikováno v:
Journal of Clinical Oncology. 38:e16593-e16593
e16593 Background: Our previous studies showed that TAI with modified FOLFOX increased tumor response and resection rate compared with conventional TACE in advanced HCC. PD-1/PD-L1 inhibitors have been demonstrated promising value in HCC. This study